Amicus Therapeutics Inc FOLD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 5:36 PM EDT
9.95quote price arrow up+0.02 (+0.20%)
Volume
168,266
Close
9.93quote price arrow down-0.27 (-2.65%)
Volume
3,349,525
52 week range
8.68 - 25.39

...

Loading . . .
  • Open9.91
  • Day High10.08
  • Day Low9.68
  • Prev Close10.20
  • 52 Week High25.39
  • 52 Week High Date12/22/20
  • 52 Week Low8.68
  • 52 Week Low Date05/25/21

Key Stats

  • Market Cap2.642B
  • Shares Out266.06M
  • 10 Day Average Volume2.23M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change-56.99

KEY STATS

  • Open9.91
  • Day High10.08
  • Day Low9.68
  • Prev Close10.20
  • 52 Week High25.39
  • 52 Week High Date12/22/20
  • 52 Week Low8.68
  • 52 Week Low Date05/25/21
  • Market Cap2.642B
  • Shares Out266.06M
  • 10 Day Average Volume2.23M
  • Dividend-
  • Dividend Yield-
  • Beta1.11
  • YTD % Change-56.99

RATIOS/PROFITABILITY

  • EPS (TTM)-0.97
  • P/E (TTM)-10.21
  • Fwd P/E (NTM)-11.72
  • EBITDA (MRQ)-213.31M
  • ROE (MRQ)-77.60%
  • Revenue (MRQ)266.76M
  • Gross Margin (MRQ)88.37%
  • Net Margin (MRQ)-95.05%
  • Debt To Equity (MRQ)155.36%

EVENTS

  • Earnings Date08/09/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amicus Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The Company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; clinical-stage, treatment...
John Crowley J.D.
Chairman
Bradley Campbell
President
Daphne Quimi CPA
Chief Financial Officer
Samantha Prout CPA
Chief Accounting Officer
Ellen Rosenberg J.D.
General Counsel
Address
3675 MARKET STREET
Philadelphia, PA
19104
United States

Top Peers

SYMBOLLASTCHG%CHG
PTCT
PTC Therapeutics Inc
44.64+0.42+0.95%
MOR
MorphoSys AG
19.36-0.63-3.15%
BLUE
bluebird bio Inc
33.15+0.17+0.52%
DRNA
Dicerna Pharmaceuticals Inc
36.18+0.40+1.12%
FGEN
FibroGen Inc
26.96+0.67+2.55%